Regent Pacific Group Ltd

RPG

Company Profile

  • Business description

    Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.

  • Contact

    5 Queen's Road Central
    8th Floor, Henley Building
    Hong Kong
    HKG

    T: +852 25146111

    https://www.endurancerp.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    16

Stocks News & Analysis

stocks

Nvidia: Hugging Face acquisition both a wise offensive and defensive move

We think this improves Nvidia’s position within the open-source community.
stocks

Anthropic’s IPO will be huge—and risky. Here are the challenges investors should watch

Part two of a Q&A with PitchBook senior analyst Harrison Rolfes about Anthropic, the AI giant’s challenges, and how much it’s worth.
stocks

Chart of the Week: China demand for copper falls amidst record rally

Elevated copper prices raise valuation questions.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,198.2052.40-0.57%
CAC 408,286.405.770.07%
DAX 4026,003.32163.990.63%
Dow JONES (US)53,686.11624.161.18%
FTSE 10010,831.5275.070.70%
HKSE25,748.83535.522.12%
NASDAQ26,584.06366.231.40%
Nikkei 22564,769.74555.260.86%
NZX 50 Index13,936.0989.910.65%
S&P 5007,747.7181.111.06%
S&P/ASX 2009,009.3060.90-0.67%
SSE Composite Index3,958.3516.270.41%

Market Movers